Tag : MedicalMarijuanaInc

CCT Impact

Global Medical Cannabis Market Report 2021 Featuring Aphria, Aurora Cannabis, Cannabis Science, Canopy Growth, Medical Marijuana, Inc, VIVO Cannabis, Tikun Olam, Tilray, The Cronos Group & CANVORY

CCT IMPACT Agent
The “Medical Cannabis Market Forecast to 2028 – COVID-19 Impact and Global Analysis By Product Type, Medical Application, and Geography” report has been added to ResearchAndMarkets.com’s offering. The global medical cannabis market is expected to reach US$ 49,116.4 million by 2028 from US$ 8,926.6 million in 2020. It is estimated to grow at a CAGR of 23.9% from......
Market Watch

Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Announces June 2020 as the Largest Sales Bookings Month in Company History

CCT IMPACT Agent
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary HempMeds® Mexico had its largest-ever sales bookings month in the Company’s history in June 2020. “Raul Elizalde, who was just promoted from President......
Market Watch

Medical Marijuana, Inc. Subsidiary HempMeds® Co-CEO Caroline Heinz Featured in Yahoo! Finance

CCT IMPACT Agent
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that Caroline Heinz, co-CEO of its subsidiary HempMeds®, was featured in the major business publication Yahoo! Finance. The article in Yahoo! Finance entitled “The Brazilian......
CCT Impact

Medical Marijuana, Inc. Subsidiary Kannaway® Promotes Stephen Jones to President

CCT IMPACT Agent
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its subsidiary Kannaway® has promoted the Company’s Chief Marketing Officer Stephen Jones to President. Stephen Jones, President of Kannaway® “Over the past three years, Stephen......
CCT Impact

Medical Marijuana, Inc. Investment Company AXIM® Biotechnologies Receives New U.S. Patent Issuance for Chewing Gum Comprising Cannabinoids and Nicotine

CCT IMPACT Agent
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its investment company AXIM® Biotechnologies, Inc. (OTCQB: AXIM) (“AXIM® Biotech” or “AXIM”) has been issued a Notice of Allowance for a patent from the United......
CCT Impact

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Receives Patent in the European Union (EU)

CCT IMPACT Agent
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that the European Patent Office has issued European Patent EP3094318B1 (the “Patent”) specific to “Novel Functionalized 1,3-Benzene Diols and their Method of Use for the......
CCT Impact

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Strengthens Intellectual Property Portfolio with New Chinese-Issued Patent

CCT IMPACT Agent
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that China has issued Chinese Patent CN106456573B (the “Patent”) specific to “Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy”......
Market Watch

Medical Marijuana, Inc. Portfolio Investment Company Kannalife, Inc. Announces Completion of NIH-NIDA Phase 1 Grant and Results from Temple University

CCT IMPACT Agent
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that its portfolio investment company Kannalife, Inc. (“Kannalife”) (OTC: KLFE), a biopharmaceutical company specializing in the research and development of cannabinoid therapeutics, has completed......
CCT Impact

Medical Marijuana, Inc. Flagship CBD Oil RSHO-X™ Clinical Study Results Show Promise

CCT IMPACT Agent
Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that a clinical study conducted in Mexico using its Real Scientific Hemp Oil-X™ cannabidiol (CBD) oil has been completed and published in the EC Neurology (ECNE),......
CCT Impact

Medical Marijuana, Inc. Subsidiary Kannaway® Welcomes Renowned Wellness Expert and Certified Nutrition Coach Daniel Miller as Company Spokesperson

CCT IMPACT Agent
 Medical Marijuana, Inc. (OTC: MJNA) (the “Company”), the first-ever publicly traded cannabis company in the United States that launched the world’s first-ever cannabis-derived nutraceutical products, brands and supply chain, announced today that renowned wellness expert and Certified Nutrition Coach Daniel Miller has joined its subsidiary Kannaway®. Miller, in partnership with Kannaway® as their new spokesperson, has......